Mehealthy ltd. is a pharmaceutical company specialised in skin care and plastic surgery products based in the US. Their core product is a topical treatment for non-‐melanoma skin cancer. In addition, the firm also develops and sells botulinum toxins to plastic surgeons for patients who want to reduce wrinkles. The company covers the entire line of production and distribution: it operates an R&D laboratory, manufactures the drugs and toxins in its own plants and distributes the products through its own sales force. The company’s salespeople are product specialists with a background in pharmacy or medicine who meet practitioners at conferences and seminars or directly at their clinic to inform them about the new products developed by Mehealthy. They manage the client relationship from initial contact to final sales, and follow up with new offers on a regular basis. The company’s management have noticed that their sales growth is significantly lower than that of their competitors, and believe that this is due to their sales force underperforming. They have noticed that competitors have a smaller but more specialised sales force, and have received feedback from physicians that their sales representatives are not always available. The management have asked you to evaluate potential solutions to increase their revenue growth. They give you the following data about the evolution of their sales force and their revenues over the last five years:
Which of the following values best approximates the average revenue per salesperson over the last four years in the botulinum toxins segment?
